Greenwich, Connecticut, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Belpointe PREP, LLC (“Belpointe OZ,” “we,” “us,” “our” or the “Company”) (NYSE American: OZ), a publicly traded qualified opportunity fund, announced today that the Company entered into an agreement relating to a development site located at 100 Tokeneke Road in Darien, Connecticut (the “Property”), one of the most affluent and supply-constrained residential markets in the region.
The Property is being contributed by the seller to an indirect subsidiary of Belpointe OZ in exchange for equity in the project entity. The transaction was completed without any upfront cash consideration from Belpointe OZ, though the Company intends to provide future capital in connection with the project’s development or financing, either directly or indirectly through an affiliated investment vehicle organized for that purpose. The structure establishes an initial framework for our participation in the long-term development and ownership of a ground-up luxury multifamily project in one of the most exclusive residential communities in the country.
Darien consistently ranks among the wealthiest towns in America, with limited multifamily inventory and strong long-term demand driven by proximity to New York City, top-tier schools, and a highly affluent resident base.
In addition, the agreement provides a mechanism by which Belpointe OZ may buy out the Property’s seller at a pre-agreed valuation, payable in our Class A units, further aligning long-term incentives while preserving balance-sheet flexibility.
“This transaction provides Belpointe OZ with exposure to a rare ground-up residential development opportunity in one of the highest-barrier-to-entry markets in the country,” said Brandon Lacoff, Chairman and CEO of Belpointe OZ. “We believe Darien’s demographic profile, supply constraints, and proximity to New York City create a compelling backdrop for long-term value creation.”
About Belpointe OZ
Belpointe OZ is a publicly traded qualified opportunity fund, listed on NYSE American under the symbol “OZ.” To date, Belpointe OZ has over 2,000 units in its development pipeline throughout four cities, representing an approximate total project cost of over $1.0 billion.
Belpointe OZ has filed a registration statements (including a combined prospectus) with the U.S. Securities and Exchange Commission (“SEC”) for the offer and sale of up to an aggregate of $750,000,000 of Class A units representing limited liability interests in Belpointe OZ (the “Class A units”). Before you invest, you should read Belpointe OZ’s most recent prospectus and the other documents that it has filed with the SEC for more complete information about Belpointe OZ and the offering. Investing in Belpointe OZ’s Class A units involves a high degree of risk, including a complete loss of investment. Prior to making an investment decision, you should carefully consider Belpointe OZ’s investment objectives and strategy, risk factors, fees and expenses and any tax consequences that may results from an investment in Belpointe OZ’s Class A units. To view Belpointe OZ’s most recent prospectus containing this and other important information visit sec.gov or investors.belpointeoz.com. Alternatively, you may request Belpointe OZ send you the prospectus by calling (203) 883-1944 or emailing IR@belpointeoz.com. Read the prospectus in its entirety before making an investment decision.
Cautionary Note Regarding Forward-Looking Statements
This press release (this “Press Release”) contains express or implied “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to qualify for the “safe harbor” from liability established by those sections. Forward-looking statements are based on our current beliefs and assumptions, and on information currently available to us, and only speak as of the date of this Press Release. All statements other than statements of historical fact, such as statements containing estimates, projections and other forward-looking information, are forward-looking statements. Forward-looking statements are typically identified by words and phrases such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “seek,” “should,” “will,” “would,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target” or the negative of such words and other comparable terminology. However, the absence of these words does not mean that a statement is not forward-looking. Any forward-looking statements expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and involve risks, uncertainties and other factors beyond our control, including factors described in our filings with the SEC, such as those detailed under the heading “Risk Factors” in our annual report on Form 10-K and quarterly reports on Form 10-Q. We cannot provide you with assurance that any of the assumptions upon which our forward-looking statements are based will prove to be correct. Should one or more risks materialize, or should our underlying assumptions prove incorrect, actual results may vary materially from those expressed or implied in any forward-looking statements, and you are therefore cautioned against placing undue reliance on any forward-looking statements. Except as otherwise required by applicable law, including federal securities laws, we do not intend to update or revise any forward-looking statements as a result of new information, future events, actual results, revised expectations or otherwise We further expressly disclaim any written or oral statements made by a third party regarding the subject matter of this Press Release.
Investor Relations and Media Contact:
Cody H. Laidlaw
Belpointe PREP, LLC
255 Glenville Road
Greenwich, Connecticut 06831
IR@belpointeoz.com
203-883-1944



© 2026 Canjex Publishing Ltd. All rights reserved.